Home » Topics » BioWorld Science

BioWorld Science
RSS

Affibody completes 12-week interim analysis of phase II psoriasis study of ABY-035

July 17, 2019

Skyhawk and Genentech to discover and develop small-molecule RNA splicing modifiers

July 17, 2019

Bristol-Myers Squibb presents Toll-like receptor antagonists

July 17, 2019

STING is required to restrict MCMV dissemination to lymph nodes

July 17, 2019

Boehringer Ingelheim patents SOS1 inhibitors

July 17, 2019

Chiesi Farmaceutici divulges Rho kinase inhibitors

July 17, 2019

Merck & Co. identifies PI3Kdelta inhibitors

July 17, 2019

mTORC1/mTORC2 inhibitor MTI-31 shows promise for treating lung cancer

July 17, 2019

Sichuan Kelun-Biotech Biopharmaceutical describes bile acid receptor agonists

July 17, 2019

Druggability Technologies begins phase II trial of DRGT-119 for chronic anal fissure

July 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...